dual acting HDAC inhibitor/Bax activator (Shandong University)

N/A

Report date: 2025/03/19 08:56:58
NME

Base Information

Drug Namedual acting HDAC inhibitor/Bax activator (Shandong University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis regulator BAX agonistsHistone deacetylase inhibitors
TargetsHistone deacetylaseApoptosis regulator BAX
Therapy Area/IndicationsUterine Cervical Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong University
China Registration ClassN/A

Develop Information

Active CompaniesShandong University
Inactive CompaniesN/A
Active IndicationsUterine Cervical Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A